ES2145823T3 - Agente para la profilaxis o el tratamiento de cataratas. - Google Patents
Agente para la profilaxis o el tratamiento de cataratas.Info
- Publication number
- ES2145823T3 ES2145823T3 ES94907086T ES94907086T ES2145823T3 ES 2145823 T3 ES2145823 T3 ES 2145823T3 ES 94907086 T ES94907086 T ES 94907086T ES 94907086 T ES94907086 T ES 94907086T ES 2145823 T3 ES2145823 T3 ES 2145823T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- prophylaxis
- treatment
- agent
- methylbenzoylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
UN AGENTE PARA LA PROFILAXIS O TRATAMIENTO DE CATARATAS, QUE COMPRENDE COMO UN INGREDIENTE ACTIVO AL MENOS UN COMPUESTO SELECCIONADO DEL GRUPO CONSISTENTE EN UN COMPUESTO DE CARBOESTIRILO DE FORMULA (1), EN DONDE R{SUP,1} ES UN GRUPO ALKOXI BAJO DE ALKANOILO SUSTITUIDO BAJO, Y EL ENLACE ENTRE LAS 3- Y 4-POSICIONES DEL NUCLEO DE CARBOESTIRILO ES UN ENLACE SIMPLE O UN ENLACE DOBLE, O UNA SAL DEL MISMO, 5-DIMETILAMINO-1-[[]4(()2-METILBENZOILAMINO())BENZOILO[]]-2,3,4,5-TETRAHIDRO-1HBENZACEPINA Y 5-HIDROXI-7-CLORO-1-[[]2-METILO-4-(()METILOBEZOILAMINO())BENZOILO[]]-2,3,4,5-TETRAHIDRO-1H-BENZACEPINA, UN METODO PARA PROFILAXIS O TRATAMIENTO DE CATARATAS QUE UTILIZA EL MISMO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3289693 | 1993-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2145823T3 true ES2145823T3 (es) | 2000-07-16 |
Family
ID=12371661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94907086T Expired - Lifetime ES2145823T3 (es) | 1993-02-23 | 1994-02-22 | Agente para la profilaxis o el tratamiento de cataratas. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5827862A (es) |
| EP (1) | EP0686035B1 (es) |
| KR (1) | KR100197065B1 (es) |
| CN (1) | CN1120810A (es) |
| AT (1) | ATE192041T1 (es) |
| AU (1) | AU668024B2 (es) |
| CA (1) | CA2156497A1 (es) |
| DE (1) | DE69424156T2 (es) |
| DK (1) | DK0686035T3 (es) |
| ES (1) | ES2145823T3 (es) |
| MX (1) | MX9401350A (es) |
| TW (1) | TW354762B (es) |
| WO (1) | WO1994018975A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09505057A (ja) * | 1993-11-19 | 1997-05-20 | ザ・ユニバーシティ・オブ・シドニー | 白内障を予防または制御するための方法 |
| DE19748763A1 (de) * | 1997-11-05 | 1999-05-06 | Hans Peter Zenner | Verwendung von Vasopressin-Antagonisten |
| US7030149B2 (en) | 2002-04-19 | 2006-04-18 | Allergan, Inc. | Combination of brimonidine timolol for topical ophthalmic use |
| TWI322689B (en) * | 2003-02-24 | 2010-04-01 | Otsuka Pharma Co Ltd | Method for treating severe heart failure and medicament therefor |
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
| US20070015691A1 (en) * | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Cyclosporin compositions |
| PT1919874E (pt) * | 2005-09-02 | 2011-03-14 | Otsuka Pharma Co Ltd | Processo para preparar compostos de benzazepina ou sais dos mesmos |
| US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
| CN107915752B (zh) * | 2017-11-14 | 2018-09-18 | 牡丹江医学院 | 一种治疗白内障的药物及其制备方法 |
| WO2020123312A1 (en) | 2018-12-09 | 2020-06-18 | Weinberg Assa | Method to prevent and treat macular degeneration by vasodilators |
| WO2020123852A1 (en) * | 2018-12-15 | 2020-06-18 | Weinberg Assa | Method to prevent and treat ocular cataract by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69009785T2 (de) * | 1989-02-10 | 1994-11-03 | Otsuka Pharma Co Ltd | Carbostyrilderivate. |
| JP2905909B2 (ja) * | 1991-04-19 | 1999-06-14 | 大塚製薬株式会社 | バソプレシン拮抗剤 |
| DK0450097T3 (da) * | 1989-10-20 | 1996-05-20 | Otsuka Pharma Co Ltd | Benzoheterocykliske forbindelser |
-
1994
- 1994-02-16 TW TW083101214A patent/TW354762B/zh active
- 1994-02-22 EP EP94907086A patent/EP0686035B1/en not_active Expired - Lifetime
- 1994-02-22 CN CN94191767A patent/CN1120810A/zh active Pending
- 1994-02-22 ES ES94907086T patent/ES2145823T3/es not_active Expired - Lifetime
- 1994-02-22 KR KR1019950703554A patent/KR100197065B1/ko not_active IP Right Cessation
- 1994-02-22 CA CA002156497A patent/CA2156497A1/en not_active Abandoned
- 1994-02-22 AU AU60460/94A patent/AU668024B2/en not_active Ceased
- 1994-02-22 MX MX9401350A patent/MX9401350A/es unknown
- 1994-02-22 DE DE69424156T patent/DE69424156T2/de not_active Expired - Fee Related
- 1994-02-22 AT AT94907086T patent/ATE192041T1/de not_active IP Right Cessation
- 1994-02-22 US US08/507,333 patent/US5827862A/en not_active Expired - Fee Related
- 1994-02-22 WO PCT/JP1994/000265 patent/WO1994018975A1/en active IP Right Grant
- 1994-02-22 DK DK94907086T patent/DK0686035T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0686035A1 (en) | 1995-12-13 |
| DE69424156T2 (de) | 2000-09-14 |
| CN1120810A (zh) | 1996-04-17 |
| AU668024B2 (en) | 1996-04-18 |
| US5827862A (en) | 1998-10-27 |
| CA2156497A1 (en) | 1994-09-01 |
| KR100197065B1 (ko) | 1999-06-15 |
| EP0686035B1 (en) | 2000-04-26 |
| DK0686035T3 (da) | 2000-08-07 |
| KR960700719A (ko) | 1996-02-24 |
| MX9401350A (es) | 1994-08-31 |
| DE69424156D1 (de) | 2000-05-31 |
| AU6046094A (en) | 1994-09-14 |
| TW354762B (en) | 1999-03-21 |
| ATE192041T1 (de) | 2000-05-15 |
| WO1994018975A1 (en) | 1994-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT76473A (en) | 5-(2-imidazolidinylidene-amino)benzimidazole derivatives, pharmaceutical compositions containing them and their use as alpha-2 adrenoreceptor agonists | |
| ES2145823T3 (es) | Agente para la profilaxis o el tratamiento de cataratas. | |
| FI943948A (fi) | Heterosykliset hiilihappojohdannaiset | |
| ATE223419T1 (de) | Kondensierte thiadiazolderivate, verfahren zu ihrer herstellung und deren verwendung | |
| DE69425431T2 (de) | 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren | |
| NO971470L (no) | Nye pyrimidon-derivater med fungicid aktivitet | |
| DE69420579D1 (de) | 9-HYDROXY-PYRIDO [1,2-a] PYRIMIDIN-4-ON-ETHER-DERIVATE | |
| ES2149777T3 (es) | Derivados de triazol que tienen actividad antifungica. | |
| MXPA02002452A (es) | Agentes preventivos y terapeuticos para enfermedades de oftalmicas. | |
| DK0674515T3 (da) | Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8 | |
| KR900018091A (ko) | 진경제 | |
| PL313037A1 (en) | Phenoxphenylocyclopententenylohydroxyureas | |
| AU7587396A (en) | Ocular depressor | |
| MX9701010A (es) | Un preventivo y un remedio para herida y/o inflamacion oftalmica. | |
| NO964921L (no) | Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse | |
| HU9204172D0 (en) | Method for producing n-(3-/2-(1h-imidazole-1-yl)-ethoxi-phenyl)-4-(2-thienyl)-2-pyridine-amine and its medically acceptable salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 686035 Country of ref document: ES |